J Natl Cancer Inst 2006 Jul 5
Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Related Questions
New answer by Medical Oncologist at Penn Medicine, University of Pennsylvania Health System (July 6, 2017)
This is a difficult situation given that the literature is contradictory on this topic. Both tamoxifen and a factor V Leiden mutation independently increase risk of thromboemb...